tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mathew Blackman, 52 are a HOLD (31.9%), 111 are a BUY (68.1%).
Analyst Mathew Blackman, currently employed at TD COWEN, carries an average stock price target met ratio of 62.98% that have a potential upside of 28.78% achieved within 134 days. Previously, Mathew Blackman worked at STIFEL.
Mathew Blackman’s has documented 326 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PODD, Insulet at 06-Aug-2026.
Analyst best performing recommendations are on CSII (CARDIOVASCULAR SYSTEMS).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 2/5/2024. The price target of $24 was fulfilled within 1 day with a profit of $1.1 (4.8%) receiving and performance score of 48.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Feb-2022
$9
$3.36 (59.57%)
$15
13 days ago
(17-Sep-2026)
1/16 (6.25%)
$3.24 (56.25%)
15
Buy Since 13-May-2021
$10
$4.36 (77.30%)
$14
1 months 24 days ago
(06-Aug-2026)
6/12 (50%)
$3.95 (65.29%)
347
Buy Since 08-Mar-2022
$8
$2.36 (41.84%)
$15
1 months 24 days ago
(06-Aug-2026)
5/10 (50%)
$1.95 (32.23%)
547
Buy Since 18-Mar-2021
$9
$3.36 (59.57%)
$14
1 months 25 days ago
(05-Aug-2026)
9/19 (47.37%)
$2.5 (38.46%)
362
Hold Since 21-Jul-2026
$13
$7.36 (130.50%)
$21
2 months 9 days ago
(21-Jul-2026)
2/8 (25%)
$1.79 (15.97%)
28
Which stock is Mathew Blackman most bullish on?
Which stock is Mathew Blackman most reserved on?
What Year was the first public recommendation made by Mathew Blackman?
